Jump to Main Content
Mucus permeating self-emulsifying drug delivery systems (SEDDS): About the impact of mucolytic enzymes
- Efiana, Nuri Ari, Phan, Thi Nhu Quynh, Wicaksono, Arko Jatmiko, Bernkop- Schnürch, Andreas
- Colloids and Surfaces B: Biointerfaces 2018 v.161 pp. 228-235
- bromelains, chlorides, colloids, droplet size, drug delivery systems, fluorescein diacetate, mucus, papain, swine, trypsin, zeta potential
- This study aimed to improve the mucus permeating properties of self-emulsifying drug delivery systems (SEDDS) by anchoring lipidized bromelain, papain and trypsin using palmitoyl chloride. SEDDS containing enzyme-palmitate conjugates were characterized regarding droplet size and zeta potential. Their mucus permeating properties were evaluated by Transwell diffusion and rotating tube method using fluorescein diacetate (FDA) as marker. Degree of substitution of modified enzymes was 35.3%, 47.8% and 38.5% for bromelain-palmitate, papain-palmitate and trypsin-palmitate, respectively. SEDDS as control and SEDDS containing enzyme-palmitate conjugates displayed a droplet size less than 50nm and 180–312nm as well as a zeta potential of −3 to −4 and −4 to −5mV, respectively. The highest percentage of permeation was achieved by introducing 5% papain-palmitate into SEDDS. It could enhance the mucus permeation of SEDDS in porcine intestinal mucus 4.6-fold and 2-fold as evaluated by Transwell diffusion and rotating tube method, respectively. It is concluded that mucus permeation of SEDDS can be strongly improved by incorporation of enzyme-palmitate conjugates.